Table 1 Baseline characteristics, anthropometric, and laboratory data of the studied patients
| Â | All studied patients (57 patients) | Obese patients (17 patients) | Non-obese patients (40 patients) | P value |
|---|---|---|---|---|
Age on study (years) | ||||
 Median (IQR) | 14.9 (11.15, 17.0) | 16.6 (15.4, 17.0) | 12.8 (9.8, 16.8) | 0.001* |
 [Minimum-maximum] | [5.1-18] | [11.7-18] | [5.1-18] | |
Sex | ||||
 Male:female | 24 (40.4%):33 (59.6) | 5 (23.5%):12 (76.5%) | 19 (47.5%):21 (52.5%) | 0.15 |
Type of malignancy | ||||
 Leukemia/lymphoma | 41 (71.9%) | 12 (70.6%) | 29 (72.5%) | 0.88 |
 Solid tumor | 16 (28.1%) | 5 (29.4%) | 11 (27.5%) | |
Weight (kg) | 44.97 ± 19.1 | 68.9 ± 12.9 | 33.8 ± 10.8 | < 0.001* |
BMI (kg/m2) | 21.11 ± 5.97 | 29.4 ± 3.27 | 17.0 ± 1.96 | < 0.001* |
Initial VD status | ||||
 VDD (25OH-VD < 20 ng/ml) | 35 (61.4%) | 15 (88.2%) | 20 (50%) | 0.020* |
 VDI (25OH-VD, 20-30 ng/ml) | 15 (26.3%) | 1 (5.9%) | 14 (35%) |  |
 VDS (25OH-VD ≥ 30 ng/ml) | 7 (12.3%) | 1 (5.9%) | 6 (15%) |  |
Calcium (mg/dl) | 9.8 ± 0.7 | 9.9 ± 0.5 | 9.7 ± 0.6 | 0.27 |
Phosphorus (mg/dl) | 5.2 ± 1.5 | 5.2 ± 1.3 | 5.3 ± 1.8 | 0.33 |
Magnesium (mg/dl) | 2.43 + 0.32 | 2.31 ± 0.25 | 2.45 ± 0.30 | 0.09 |
PTH (pgm/ml) | 44.5 ± 9.0 | 44.7 ± 10.7 | 45.4 ± 9.2 | 0.53 |
TC (mg/dl) | 175.51 + 49.73 | 182.6 ± 22.3 | 171.4 ± 24.2 | 0.014* |
TG (mg/dl) | 85.35 + 31.89 | 88.7 ± 45.2 | 83.0 ± 24.3 | 0.64 |
HDL-C (mg/dl) | 41.67 + 12.24 | 42.5 ± 12.6 | 41.5 ± 11.3 | 0.966 |
LDL-C (mg/dl) | 104.86 + 20.39 | 109.8 ± 26.8 | 90.5 ± 25.3 | 0.039* |